Pietr R. Cullis
Affiliations: | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Area:
General BiophysicsGoogle:
"Pietr Cullis"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kulkarni JA, Witzigmann D, Leung J, et al. (2019) On the role of helper lipids in lipid nanoparticle formulations of siRNA. Nanoscale |
| Zhang W, Böttger R, Qin Z, et al. (2019) Phospholipid-Free Small Unilamellar Vesicles for Drug Targeting to Cells in the Liver. Small (Weinheim An Der Bergstrasse, Germany). e1901782 |
| Kulkarni JA, Witzigmann D, Chen S, et al. (2019) Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics. Accounts of Chemical Research |
| Ramezanpour M, Schmidt ML, Bodnariuc I, et al. (2019) Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function. Nanoscale |
| Jyotsana N, Sharma A, Chaturvedi A, et al. (2019) Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo. Annals of Hematology |
| Kulkarni JA, Witzigmann D, Leung J, et al. (2019) Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads. Nanoscale |
| Buck J, Grossen P, Cullis PR, et al. (2019) Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery. Acs Nano |
| Maclachlan I, Cullis P. (2019) "Diffusible-PEG-Lipid Stabilized Plasmid Lipid Particles" Advances in Genetics. 157-188 |
| Kulkarni JA, Cullis PR, van der Meel R. (2018) Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility. Nucleic Acid Therapeutics |
| Kulkarni JA, Darjuan MM, Mercer JE, et al. (2018) On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA. Acs Nano |